|Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27|
M Pagano, SW Tam, AM Theodoras, P Beer-Romero, G Del Sal, V Chau, ...
Science 269 (5224), 682-685, 1995
|Cyclin D1 is a nuclear protein required for cell cycle progression in G1.|
V Baldin, J Lukas, MJ Marcote, M Pagano, G Draetta
Genes & development 7 (5), 812-821, 1993
|Cyclin A is required at two points in the human cell cycle.|
M Pagano, R Pepperkok, F Verde, W Ansorge, G Draetta
The EMBO journal 11 (3), 961-971, 1992
|Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas|
M Loda, B Cukor, SW Tam, P Lavin, M Fiorentinc, GF Draetta, JM Jessup, ...
Nature medicine 3 (2), 231, 1997
|Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement|
G Draetta, D Beach
Cell 54 (1), 17-26, 1988
|Phosphorylation and activation of human cdc25‐C by cdc2‐‐cyclin B and its involvement in the self‐amplification of MPF at mitosis.|
I Hoffmann, PR Clarke, MJ Marcote, E Karsenti, G Draetta
The EMBO journal 12 (1), 53-63, 1993
|Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF|
G Draetta, F Luca, J Westendorf, L Brizuela, J Ruderman, D Beach
Cell 56 (5), 829-838, 1989
|Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation|
A Montagnoli, F Fiore, E Eytan, AC Carrano, GF Draetta, A Hershko, ...
Genes & development 13 (9), 1181-1189, 1999
|CDC25 phosphatases as potential human oncogenes|
K Galaktionov, AK Lee, J Eckstein, G Draetta, J Meckler, M Loda, D Beach
Science 269 (5230), 1575-1577, 1995
|FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors|
J O'Neil, J Grim, P Strack, S Rao, D Tibbitts, C Winter, J Hardwick, ...
Journal of Experimental Medicine 204 (8), 1813-1824, 2007
|Activation of the phosphatase activity of human cdc25A by a cdk2‐cyclin E dependent phosphorylation at the G1/S transition.|
I Hoffmann, G Draetta, E Karsenti
The EMBO journal 13 (18), 4302-4310, 1994
|Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function|
A Viale, P Pettazzoni, CA Lyssiotis, H Ying, N Sánchez, M Marchesini, ...
Nature 514 (7524), 628, 2014
CB Klee, GF Draetta, MJ Hubbard
Advances in enzymology and related areas of molecular biology 61, 149-200, 1988
|The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas|
P Tan, B Cady, M Wanner, P Worland, B Cukor, C Magi-Galluzzi, P Lavin, ...
Cancer research 57 (7), 1259-1263, 1997
|Regulating mammalian checkpoints through Cdc25 inactivation|
M Donzelli, GF Draetta
EMBO reports 4 (7), 671-677, 2003
|Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies activation during entry into mitosis|
AO Morla, G Draetta, D Beach, JYJ Wang
Cell 58 (1), 193-203, 1989
|Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage|
L Busino, M Donzelli, M Chiesa, D Guardavaccaro, D Ganoth, NV Dorrello, ...
Nature 426 (6962), 87, 2003
|The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells|
K Riabowol, G Draetta, L Brizuela, D Vandre, D Beach
Cell 57 (3), 393-401, 1989
|Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation|
Trends in biochemical sciences 15 (10), 378-383, 1990
|p13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase.|
L Brizuela, G Draetta, D Beach
The EMBO Journal 6 (11), 3507-3514, 1987